Sample Recruitment Email
RE: Mycoplasma genitalium Treatment Failure Registry
Dear Provider,
Mycoplasma genitalium has been associated with several clinical syndromes including recurrent urethritis and cervicitis; it has also been detected among men with proctitis. Few antibiotics are available to treat M. genitalium. Resistance of M. genitalium to azithromycin has been documented worldwide and is associated with treatment failure. There have also been reports of antibiotic resistance to moxifloxacin, the treatment recommended by the Centers for Disease Control and Prevention (CDC) Sexually Transmitted Treatment Guidelines for macrolide-resistant M.genitalium infections.
The Division of STD Control and Prevention (DSTDP) at the CDC is initiating the Mycoplasma genitalium Treatment Failure Registry, a national registry to monitor M. genitalium clinical treatment failure with CDC recommended therapy, to determine the antimicrobial regimen prescribed for persistent infection, and to monitor antimicrobial resistance patterns throughout the United States.
Who is eligible?
Eligible patients include those with 1) recurrent urethritis, cervicitis or proctitis, 2) a positive nucleic acid amplification test (NAAT) for M. genitalium, AND 3) persistent symptoms and positive repeat NAAT after CDC-recommended treatment.
How should I report cases?
CDC is requesting that providers complete a case report form which can be found at:
HYPERLINK TO CASE REPORT FORM ONCE LIVE
Providers will be asked for their contact information. For case patients, providers will be asked to report on demographic and clinical characteristics, including dates of testing and antimicrobial treatment. Providers will not report any personally identifiable information to the CDC. If remnant specimens are available, CDC staff will coordinate shipment to the CDC Laboratory Branch so that the specimens can be tested for genetic markers of antibiotic resistance. Case reports and remnant specimens will be linked with a shared unique identifier that does not contain any protected health information.
Case report forms may be scanned and sent via email to [email protected], or by fax to 404-xxx-XXXX (secure fax).
What if I need clinical consultation or have further questions?
Reporting providers who desire additional clinical consultation will be connected to expert clinicians at the STD Clinical Consultation Network. (www.stdccn.org)
Please direct questions about the Mycoplasma Treatment Failure Registry to INSERT NAME OF PROJECT OFFICER, at [email protected]
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| Author | Park, Ina |
| File Modified | 0000-00-00 |
| File Created | 2021-01-12 |